Cargando…
Vasopressor Use for Severe Hypotension—A Multicentre Prospective Observational Study
BACKGROUND: The optimal approach to titrate vasopressor therapy is unclear. Recent sepsis guidelines recommend a mean arterial pressure (MAP) target of 65 mmHg and higher for chronic hypertensive patients. As data emerge from clinical trials comparing blood pressure targets for vasopressor therapy,...
Autores principales: | Lamontagne, Francois, Cook, Deborah J., Meade, Maureen O., Seely, Andrew, Day, Andrew G., Charbonney, Emmanuel, Serri, Karim, Skrobik, Yoanna, Hebert, Paul, St-Arnaud, Charles, Quiroz-Martinez, Hector, Mayette, Michaël, Heyland, Daren K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5249049/ https://www.ncbi.nlm.nih.gov/pubmed/28107357 http://dx.doi.org/10.1371/journal.pone.0167840 |
Ejemplares similares
-
Optimal VAsopressor TitraTION in patients 65 years and older (OVATION-65): protocol and statistical analysis plan for a randomised clinical trial
por: Masse, Marie-Hélène, et al.
Publicado: (2020) -
Hypotension in ICU Patients Receiving Vasopressor Therapy
por: Yapps, Bryce, et al.
Publicado: (2017) -
Cultural adaptation of a community‐based advance serious illness planning decision aid to the Quebec context involving end‐users
por: Plaisance, Ariane, et al.
Publicado: (2022) -
Lower Versus Higher Exposure to Vasopressor Therapy in Vasodilatory Hypotension: A Systematic Review With Meta-Analysis*
por: Richards-Belle, Alvin, et al.
Publicado: (2022) -
Modeling of Usual Care: Vasopressor Initiation for Sepsis With Hypotension
por: Prasad, Varesh, et al.
Publicado: (2022)